Charles G. Drake
Charles G. Drake
Verified email at
Cited by
Cited by
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
SL Topalian, FS Hodi, JR Brahmer, SN Gettinger, DC Smith, ...
New England Journal of Medicine 366 (26), 2443-2454, 2012
Safety and activity of anti–PD-L1 antibody in patients with advanced cancer
JR Brahmer, SS Tykodi, LQM Chow, WJ Hwu, SL Topalian, P Hwu, ...
New England Journal of Medicine 366 (26), 2455-2465, 2012
Phase I study of single-agent anti–programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
JR Brahmer, CG Drake, I Wollner, JD Powderly, J Picus, WH Sharfman, ...
Journal of clinical oncology 28 (19), 3167, 2010
Immune checkpoint blockade: a common denominator approach to cancer therapy
SL Topalian, CG Drake, DM Pardoll
Cancer cell 27 (4), 450-461, 2015
A draft map of the human proteome
MS Kim, SM Pinto, D Getnet, RS Nirujogi, SS Manda, R Chaerkady, ...
Nature 509 (7502), 575-581, 2014
Inflammation in prostate carcinogenesis
AM De Marzo, EA Platz, S Sutcliffe, J Xu, H Grönberg, CG Drake, Y Nakai, ...
Nature Reviews Cancer 7 (4), 256-269, 2007
Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity
SL Topalian, CG Drake, DM Pardoll
Current opinion in immunology 24 (2), 207-212, 2012
Role of LAG-3 in regulatory T cells
CT Huang, CJ Workman, D Flies, X Pan, AL Marson, G Zhou, EL Hipkiss, ...
Immunity 21 (4), 503-513, 2004
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a …
ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ...
The lancet oncology 15 (7), 700-712, 2014
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ...
Cancer research 72 (4), 917-927, 2012
Mechanisms of immune evasion by tumors
CG Drake, E Jaffee, DM Pardoll
Advances in immunology 90, 51-81, 2006
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
J Zeng, AP See, J Phallen, CM Jackson, Z Belcaid, J Ruzevick, N Durham, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 343-349, 2013
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity
TJ Harris, JF Grosso, HR Yen, H Xin, M Kortylewski, E Albesiano, ...
The Journal of Immunology 179 (7), 4313-4317, 2007
Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma
S Lyford-Pike, S Peng, GD Young, JM Taube, WH Westra, B Akpeng, ...
Cancer research 73 (6), 1733-1741, 2013
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody
EJ Lipson, WH Sharfman, CG Drake, I Wollner, JM Taube, RA Anders, ...
Clinical Cancer Research 19 (2), 462-468, 2013
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment
M Kortylewski, H Xin, M Kujawski, H Lee, Y Liu, T Harris, C Drake, ...
Cancer cell 15 (2), 114-123, 2009
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
PE Zarek, CT Huang, ER Lutz, J Kowalski, MR Horton, J Linden, ...
Blood 111 (1), 251-259, 2008
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing
KS Sfanos, TC Bruno, CH Maris, L Xu, CJ Thoburn, AM DeMarzo, ...
Clinical Cancer Research 14 (11), 3254-3261, 2008
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems
JF Grosso, CC Kelleher, TJ Harris, CH Maris, EL Hipkiss, A De Marzo, ...
The Journal of clinical investigation 117 (11), 3383-3392, 2007
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
CG Drake, EJ Lipson, JR Brahmer
Nature reviews Clinical oncology 11 (1), 24, 2014
The system can't perform the operation now. Try again later.
Articles 1–20